OTHERONGOING

Eli Lilly Joins $120M Virginia Pharmaceutical Investment

VIPC executed a Memorandum of Understanding involving AstraZeneca, Eli Lilly, and Merck to support a $120M industry investment in the Virginia Center for Advanced Pharmaceutical Manufacturing. The minutes do not specify an individual amount or term for Eli Lilly.

Document date · December 2, 2025

Track Virginia Innovation Partnership Authority (VIPA) contracts

Get alerts when new contracts are awarded or existing ones approach renewal at Virginia Innovation Partnership Authority (VIPA).

Get started free

Create a free account · no credit card

Trusted by 200+ enterprise customers and 1,000+ teams on the free plan

Motive logo
Veritone logo
TerraCycle logo
Cyvl logo
WithersRavenel logo
Derivita logo
Comcate logo
SafeTouch logo
IANS Research logo
Motive logo
Veritone logo
TerraCycle logo
Cyvl logo
WithersRavenel logo
Derivita logo
Comcate logo
SafeTouch logo
IANS Research logo
Motive logo
Veritone logo
TerraCycle logo
Cyvl logo
WithersRavenel logo
Derivita logo
Comcate logo
SafeTouch logo
IANS Research logo
Motive logo
Veritone logo
TerraCycle logo
Cyvl logo
WithersRavenel logo
Derivita logo
Comcate logo
SafeTouch logo
IANS Research logo

Scope & details

The full contract record, as filed.

Contract amount
$120M industry investment (aggregate investment referenced for AstraZeneca, Eli Lilly, and Merck)
Contract type
OTHER
Document type
Minutes
Source document
Virginia Innovation Partnership Authority Minutes Joint Board Meeting December 2, 2025

Related contracts

Other contracts from Eli Lilly.

View all →

Frequently asked questions

Common questions about this contract, answered from the record.

Who was awarded the government contract by Virginia Innovation Partnership Authority (VIPA)?

Eli Lilly was awarded this government contract by Virginia Innovation Partnership Authority (VIPA), as recorded on December 2, 2025. The contract value is $120M industry investment (aggregate investment referenced for AstraZeneca, Eli Lilly, and Merck).

How much is the Eli Lilly contract with Virginia Innovation Partnership Authority (VIPA) worth?

The Eli Lilly contract with Virginia Innovation Partnership Authority (VIPA) is valued at $120M industry investment (aggregate investment referenced for AstraZeneca, Eli Lilly, and Merck).

What type of contract is this?

This is a government contract, documented as a minutes record.

Where was this contract approved?

This contract appears in Virginia Innovation Partnership Authority Minutes Joint Board Meeting December 2, 2025 (Minutes), dated December 2, 2025 from Virginia Innovation Partnership Authority (VIPA). Civic IQ extracts contract records directly from agency meeting documents and solicitations.

What other contracts does Eli Lilly hold?

Eli Lilly may hold additional government contracts. View their full contract history, the agencies they serve, and total tracked spend on their Civic IQ vendor profile.

View Eli Lilly's profile

What is Virginia Innovation Partnership Authority (VIPA) currently buying?

Explore Virginia Innovation Partnership Authority (VIPA)'s vendors, signed contracts, and active RFPs on their Civic IQ agency profile.

View Virginia Innovation Partnership Authority (VIPA)'s profile